Latest News
- Freight Surge and Gulf Tensions Threaten India’s Pharma Exports; Industry Flags Potential ?5,000-Crore Impact
- Min. Nadda Unveils ?13,000-Crore Bio-Pharma SHAKTI and Chemical Parks Push to Expand India’s Global Chemicals and Biologics Footprint
- Aurobindo Pharma Subsidiary Launches Generic Cancer Drug in US, Expands Oncology Portfolio in Global Generics Market
British doctors report cases of spontaneous recovery from irreversible heart disease
According to Gazeta.ru, three individuals who were previously diagnosed with cardiac amyloidosis, a condition characterized by the accumulation of toxic proteins in the heart tissues leading to heart failure, have experienced spontaneous recovery from the disease. The information is sourced from The New England Journal of Medicine.
Typically, the prognosis for this disease is unfavorable, with approximately half of patients succumbing to the condition within four years of diagnosis. Transthyretin, a toxic amyloid protein, is known to cause irreversible heart failure in these cases.
The reported cases involve three men aged 68, 76, and 82, who initially received a diagnosis of transthyretin cardiac amyloidosis. However, they later exhibited positive developments. The patients reported an improvement in their well-being to their doctors, and cardiovascular scans confirmed the disappearance of amyloid proteins from their heart tissues.
Interestingly, instead of the toxic protein, antibodies were discovered in the hearts of these individuals, which were found to be responsible for destroying transthyretin. This occurrence is quite rare, as no similar positive changes were observed in the remaining 350 patients, who experienced continued progression of the disease.
Medical professionals are in the process of gathering evidence to support the hypothesis that these antibodies are the cause of the spontaneous healing observed in amyloidosis. If this hypothesis is validated, it may pave the way for the use of such antibodies as a potential therapy for amyloidosis.